Literature DB >> 31069605

Zinc and iron complexes of oleanolic acid, (OA) attenuate allergic airway inflammation in rats.

Adnan Jehangir1,2, Muhammad Shahzad3, Khadija Shahid2, Akbar Waheed2, Farhana Ayub2.   

Abstract

Oleanolic acid (OA) is a hydroxyl pentacyclic triterpene acid (HTAs) used in various ailments. Inflammatory diseases may be profoundly influenced by iron (Fe) and zinc (Zn) status. We studied the anti-asthmatic effects of two metal complexes (Fe and Zn) of OA in the ovalbumin (OVA)-induced rat model. Delayed type hypersensitivity (DTH) was measured. Total and differential leucocyte count was done in blood as well as bronchoalveolar lavage fluid (BALF). The mRNA expression levels of pro-inflammatory cytokines were measured in lung tissue by reverse transcription polymerase chain reaction. The levels of cyclooxygenase-2 (COX-2), immunoglobulin E (IgE) and 5-lipoxygenase (5-LOX) were estimated by enzyme linked immunosorbent assay. Splenocyte proliferation was performed through BrdU uptake method and nitric oxide levels were measured by colorimetric assay kit. The acute toxicity study was also done for the complexes. The asthmatic group developed allergic airway inflammation shown by increased DTH and inflammatory markers in blood and BALF. OA + Fe and OA + Zn displayed significant decrease in DTH, NO, expression of IL-4, 5, 13, 17, toll-like receptor-2, nuclear factor-kappa B and tumor necrosis factor-α; serum IgE, COX-2, and 5-LOX. The metal complexes also attenuated OVA-stimulated splenocyte proliferation. While no hepatotoxic or nephrotoxic potential was shown by OA + Fe and OA + Zn. Our findings indicate that both OA + Fe and OA + Zn possess significant anti-asthmatic effect which may be ascribed to its immunomodulatory and anti-inflammatory features.

Entities:  

Keywords:  5-Lipoxygenase (5-LOX); Allergic asthma (AA); Bronchoalveolar lavage fluid (BALF); Cyclooxygenase-2 (COX-2); Immunoglobulin E (IgE); Iron (Fe); Oleanolic acid (OA); Zinc (Zn)

Mesh:

Substances:

Year:  2019        PMID: 31069605     DOI: 10.1007/s10787-019-00597-2

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  66 in total

1.  Contribution of alveolar type II cell-derived cyclooxygenase-2 to basal airway function, lung inflammation, and lung fibrosis.

Authors:  Jennifer Cheng; Ryan T Dackor; J Alyce Bradbury; Hong Li; Laura M DeGraff; Lee K Hong; Debra King; Fred B Lih; Artiom Gruzdev; Matthew L Edin; Gregory S Travlos; Gordon P Flake; Kenneth B Tomer; Darryl C Zeldin
Journal:  FASEB J       Date:  2015-09-22       Impact factor: 5.191

2.  Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci.

Authors:  A LeGrand; B Fermor; C Fink; D S Pisetsky; J B Weinberg; T P Vail; F Guilak
Journal:  Arthritis Rheum       Date:  2001-09

3.  Zingiber officinale ameliorates allergic asthma via suppression of Th2-mediated immune response.

Authors:  Asad Mahmood Khan; Muhammad Shahzad; M B Raza Asim; Muhammad Imran; Arham Shabbir
Journal:  Pharm Biol       Date:  2014-11-25       Impact factor: 3.503

4.  Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation.

Authors:  Rabab El Mezayen; Mohamed El Gazzar; Mark R Nicolls; John C Marecki; Stephen C Dreskin; Hisayuki Nomiyama
Journal:  Immunol Lett       Date:  2006-05-22       Impact factor: 3.685

5.  Tumour necrosis factor-alpha blockade suppresses murine allergic airways inflammation.

Authors:  S Hutchison; B S W Choo-Kang; R V Bundick; A J Leishman; J M Brewer; I B McInnes; P Garside
Journal:  Clin Exp Immunol       Date:  2007-10-11       Impact factor: 4.330

6.  RNA interference against interleukin-5 attenuates airway inflammation and hyperresponsiveness in an asthma model.

Authors:  Shao-xing Chen; Feng-ying Huang; Guang-hong Tan; Cai-chun Wang; Yong-hao Huang; Hua Wang; Song-lin Zhou; Fan Chen; Ying-ying Lin; Jun-bao Liu
Journal:  J Zhejiang Univ Sci B       Date:  2009-01       Impact factor: 3.066

Review 7.  Interleukin-5 and IL-5 receptor in health and diseases.

Authors:  Kiyoshi Takatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

8.  So-Cheong-Ryong-Tang, a herbal medicine, modulates inflammatory cell infiltration and prevents airway remodeling via regulation of interleukin-17 and GM-CSF in allergic asthma in mice.

Authors:  Hyung-Woo Kim; Chi-Yeon Lim; Bu-Yeo Kim; Su-In Cho
Journal:  Pharmacogn Mag       Date:  2014-08       Impact factor: 1.085

9.  The soluble tumor necrosis factor-alpha receptor suppresses airway inflammation in a murine model of acute asthma.

Authors:  Hae-Seong Nam; Sook Young Lee; Seung Jun Kim; Ju Sang Kim; Soon Seog Kwon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Jeong Sup Song; Sung Hak Park; Seok Chan Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

10.  LTC4 synthase polymorphism modifies efficacy of botanical seed oil combination in asthma.

Authors:  Shamsah Kazani; Jonathan P Arm; Joshua Boyce; Heng Chhay; Stefanie Dutile; Michael E Wechsler; Usha Govindarajulu; Priscilla Ivester; Hannah C Ainsworth; Susan Sergeant; Floyd H Chilton; Elliot Israel
Journal:  Springerplus       Date:  2014-11-06
View more
  3 in total

Review 1.  Development and Evaluation of Oleanolic Acid Dosage Forms and Its Derivatives.

Authors:  Anjie Feng; Shanjing Yang; Yue Sun; Li Zhang; Fumin Bo; Lingjun Li
Journal:  Biomed Res Int       Date:  2020-11-25       Impact factor: 3.411

Review 2.  Immunomodulatory properties of triterpenes.

Authors:  Gülin Renda; İçim Gökkaya; Didem Şöhretoğlu
Journal:  Phytochem Rev       Date:  2021-11-18       Impact factor: 7.741

3.  Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells.

Authors:  Amr Omar; Rajkumar Singh Kalra; Jayarani Putri; Ahmed Elwakeel; Sunil C Kaul; Renu Wadhwa
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.